There is insufficient evidence to suggest that medical cannabis and medicinal cannabinoids can treat or improve mental health disorders or relieve their symptoms. Researchers, who conducted a comprehensive analysis of medicinal cannabinoids and their impact on six mental health disorders – depression, anxiety, attention-deficit hyperactivity disorder (ADHD), Tourette syndrome, post-traumatic stress disorder (PTSD), and psychosis – conclude that the use of cannabinoids for mental health conditions cannot be justified due to a lack of evidence currently for their effectiveness, and because of the known risks of cannabinoids. The findings have been published in The Lancet Psychiatry journal. "Our findings have important implications in countries where cannabis and cannabinoids are being made available for medical use. There is a notable absence of high-quality evidence to properly assess the effectiveness and safety of medicinal cannabinoids compared with placebo, and until evidence from randomized controlled trials is available, clinical guidelines cannot be […]